The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Candida parapsilosis: a review of its epidemiology, pathogenesis, clinical aspects, typing and antimicrobial susceptibility
Abstract
The Candida parapsilosis family has emerged as a major opportunistic and nosocomial pathogen. It causes multifaceted pathology in immuno-compromised and normal hosts, notably low birth weight neonates. Its emergence may relate to an ability to colonize the skin, proliferate in glucose-containing solutions, and adhere to plastic. When clusters appear, determination of genetic relatedness among strains and identification of a common source are important. Its virulence appears associated with a capacity to produce biofilm and production of phospholipase and aspartyl protease. Further investigations of the host-pathogen interactions are needed. This review summarizes basic science, clinical and experimental information about C. parapsilosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Guidelines for Treatment of Candidiasis
Pappas, P. G., Rex, J. H., Sobel, J. D., Filler, S. G., Dismukes, W. E., Walsh, T. J., & Edwards, J. E. (2004) · Clinical Infectious Diseases · doi:10.1086/380796 · Cited by 1,440 · cited 20×
“In disease associated with catheters used for peritoneal dialysis, early catheter removal is often required for successful therapy for peritoneal candidiasis (Bren 1998; Kaitwatcharachai 2002; Pappas et al. 2004).”
BackgroundMethodInfluentialComparison of Caspofungin and Amphotericin B for Invasive Candidiasis
Mora-Duarte, J., Betts, R., Rotstein, C., Colombo, A. L., Thompson-Moya, L., Smietana, J., Lupinacci, R., Sable, C., Kartsonis, N., & Perfect, J. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021585 · Cited by 1,380
Candida biofilms and their role in infection
Douglas, L. J. (2003) · Trends in Microbiology · doi:10.1016/s0966-842x(02)00002-1 · Cited by 1,150
Denning, D. W. (2003) · The Lancet · doi:10.1016/s0140-6736(03)14472-8 · Cited by 1,131 · cited 1×
“Caspofungin, micafungin and anidulafungin, echinocandin antifungal agents, compromise cell wall structural integrity through non-competitive inhibition of the synthesis of 1,3-ß-D-glucan (Cappelletty & Eiselstein-McKitrick 2007; Denning 2003; Pfaller et al. 2006b).”
BackgroundFidel, P. L., Vazquez, J. A., & Sobel, J. D. (1999) · Clinical Microbiology Reviews · doi:10.1128/cmr.12.1.80 · Cited by 953
Anidulafungin versus Fluconazole for Invasive Candidiasis
Reboli, A. C., Rotstein, C., Pappas, P. G., Chapman, S. W., Kett, D. H., Kumar, D., Betts, R., Wible, M., Goldstein, B. P., Schranz, J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066906 · Cited by 894 · cited 5×
“The meaning of these higher MICs is still being investigated, but changes in the glucan synthase subunit Fks1 might explain the reduced activity of echinocandins against C. parapsilosis (Park et al. 2005; Reboli et al. 2007).”
BackgroundInfluentialSecular trends in nosocomial primary bloodstream infections in the United States, 1980–1989.
Banerjee, S. N., Emori, T. G., Culver, D. H., Gaynes, R. P., Jarvis, W. R., Horan, T., Edwards, J. R., Tolson, J., Henderson, T., Martone, W. J., et al. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90349-3 · Cited by 880 · cited 1×
“Some years ago Candida albicans accounted for 70–80% of the Candida isolates recovered from infected patients (Banerjee et al. 1991; Beck-Sague & Jarvis 1993; Fidel et al. 1999).”
BackgroundSullivan, D. J., Haynes, K. A., Bennett, D. E., Coleman, D. C., & Westerneng, T. J. (1995) · Microbiology · doi:10.1099/13500872-141-7-1507 · Cited by 763
The Epidemiology of Hematogenous Candidiasis Caused by Different Candida Species
Abi‐Said, D., Anaissie, E., Uzun, O., Raad, I., Pinzcowski, H., & Vartivarian, S. (1997) · Clinical Infectious Diseases · doi:10.1086/513663 · Cited by 755 · cited 1×
“parapsilosis is a frequent fungal colonizer of the subungual space of healthy volunteers (Abi-Said et al. 1997; McGinley et al. 1988; Weems 1992).”
BackgroundPfaller, M. A., Diekema, D. J., Gibbs, D. L., Newell, V. A., Ellis, D., Tullio, V., Rodloff, A., Fu, W., & Ling, T. A. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02117-09 · Cited by 718
Ramage, G., Saville, S. P., Thomas, D. P., & López-Ribot, J. L. (2005) · Eukaryotic Cell · doi:10.1128/ec.4.4.633-638.2005 · Cited by 678
Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/514731 · Cited by 601 · cited 2×
“C. parapsilosis causes 17–50% of fungemia in children (Abi-Said et al. 1997; Krcmery & Barnes 2002; Krcmery et al. 1999; Viscoli et al. 1999; Wingard 1995).”
BackgroundBiofilm formation by Candida species on the surface of catheter materials in vitro
Hawser, S. P., & Douglas, L. J. (1994) · Infection and Immunity · doi:10.1128/iai.62.3.915-921.1994 · Cited by 599 · cited 1×
“…of biofilms (microbial communities that are associated with solid surfaces such as intravascular catheters) (Nett et al. 2007), which results in the increase of catheterrelated candidemia and antifungal resistance related to catheter insertion (De Bernardis et al. 1999; Hawser & Douglas 1994).”
BackgroundImportance of Candida Species Other than C. albicans as Pathogens in Oncology Patients
Wingard, J. R. (1995) · Clinical Infectious Diseases · doi:10.1093/clinids/20.1.115 · Cited by 542 · cited 4×
“C. parapsilosis causes 17–50% of fungemia in children (Abi-Said et al. 1997; Krcmery & Barnes 2002; Krcmery et al. 1999; Viscoli et al. 1999; Wingard 1995).”
BackgroundInfluentialFluconazole prophylaxis against fungal colonization and infection in preterm infants.
Kaufman, D., Boyle, R., Hazen, K. C., Patrie, J. T., Robinson, M., & Donowitz, L. G. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010494 · Cited by 523 · cited 2×
“Very low birth weight children, during the first six weeks of life, have an increased risk for candidemia caused by C. parapsilosis (Kaufman et al. 2001).”
BackgroundTortorano, A. M., Peman, J., Bernhardt, H., Klingspor, L., Kibbler, C. C., Faure, O., Biraghi, E., Canton, E., Zimmermann, K., Seaton, S., et al. (2004) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-004-1103-y · Cited by 509 · cited 9×
“C. parapsilosis was identified in 15% in cancer patients (Tortorano et al. 2004).”
BackgroundInfluentialKao, A. S., Brandt, M. E., Pruitt, W. R., Conn, L. A., Perkins, B. A., Stephens, D. S., Baughman, W. S., Reingold, A. L., Rothrock, G. A., Pfaller, M. A., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/313450 · Cited by 457
Park, S., Kelly, R., Kahn, J. N., Robles, J., Hsu, M.-J., Register, E., Li, W., Vyas, V., Fan, H., Abruzzo, G., et al. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.8.3264-3273.2005 · Cited by 434
Rangel‐Frausto, M. S., Wiblin, T., Blumberg, H. M., Saiman, L., Patterson, J., Rinaldi, M., Pfaller, M., Edwards, Jr., Jarvis, W., Dawson, J., et al. (1999) · Clinical Infectious Diseases · doi:10.1086/520194 · Cited by 430
Pfaller, M. A., Jones, R. N., Messer, S. A., Edmond, M. B., & Wenzel, R. P. (1998) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(97)00192-2 · Cited by 424 · cited 2×
“It is now the fourth most common organism recovered from blood cultures among hospitalized patients in the USA (Hobson 2003; Pfaller et al. 1998b, Rangel-Frausto et al. 1999; Schaberg et al. 1991).”
BackgroundWeems, J. J. (1992) · Clinical Infectious Diseases · doi:10.1093/clinids/14.3.756 · Cited by 399
Diekema, D. J., Messer, S. A., Brueggemann, A. B., Coffman, S. L., Doern, G. V., Herwaldt, L. A., & Pfaller, M. A. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.4.1298-1302.2002 · Cited by 385 · cited 3×
“Clusters of cases involving prosthetic valves have been reported (Diekema et al. 1997). Garzoni et al. (2007) described intraoperative contamination (e.”
BackgroundInfluentialPfaller, M. A., Jones, R. N., Doern, G. V., Sader, H. S., Messer, S. A., Houston, A., Coffman, S., Hollis, R. J., & The SENTRY Participant Group (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.3.747-751.2000 · Cited by 378
KOSSOFF, E. H., BUESCHER, E. S., & KARLOWICZ, M. G. (1998) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199806000-00014 · Cited by 330
Garcia-Effron, G., Katiyar, S. K., Park, S., Edlind, T. D., & Perlin, D. S. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00262-08 · Cited by 323
Pfaller, M. A., Jones, R. N., Doern, G. V., Sader, H. S., Hollis, R. J., Messer, S. A., & Group, F. T. S. P. (1998) · Journal of Clinical Microbiology · doi:10.1128/jcm.36.7.1886-1889.1998 · Cited by 281
Pfaller, M. A., & Diekema, D. J. (2002) · Journal of Clinical Microbiology · doi:10.1128/jcm.40.10.3551-3557.2002 · Cited by 269 · cited 16×
“%) as the third most common Candida species causing nosocomial BSI, in data obtained from 49 hospitals across the United States (1999).”
BackgroundInfluentialCappelletty, D., & Eiselstein‐McKitrick, K. (2007) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1592/phco.27.3.369 · Cited by 205
Stevens, D. A., Ichinomiya, M., Koshi, Y., & Horiuchi, H. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00563-06 · Cited by 193 · cited 1×
“…demonstrating the paradoxical effect appear to be more resistant to host defenses (van Asbeck et al. 2009), possibly related to cell wall changes (Stevens et al. 2006), and thus this phenomenon may prove to be a factor in poor therapeutic response to echinocandins in some infections with this…”
BackgroundSelf-citationIncreasing incidence of Candida parapsilosis candidemia with caspofungin usage.
Forrest, G. N., Weekes, E., & Johnson, J. K. (2008) · Journal of Infection · doi:10.1016/j.jinf.2007.10.014 · Cited by 144
Invasive neonatal candidiasis: comparison of albicans and parapsilosis infection
FAIX, R. G. (1992) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199202000-00006 · Cited by 122 · cited 2×
“We suspect that the lower virulence of C. parapsilosis compared to C. albicans and some other non-albicans Candida species is a reason for the lower mortality and morbidity rates observed in adults and neonates (Faix 1992; Sullivan et al. 1995; Weems 1992).”
BackgroundTortorano, A. M., Biraghi, E., Astolfi, A., Ossi, C., Tejada, M., Farina, C., Perin, S., Bonaccorso, C., Cavanna, C., Raballo, A., et al. (2002) · Journal of Hospital Infection · doi:10.1053/jhin.2002.1261 · Cited by 116
Chamilos, G., Lewis, R. E., & Kontoyiannis, D. P. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.50.2.744-747.2006 · Cited by 47 · cited 4×
“The unique mitochondrial respiratory network of C. parapsilosis might play an important role for its decreased susceptibility to the echinocandins (Chamilos et al. 2006a).”
BackgroundInfluentialSusceptibility patterns of Candida species recovered from Canadian intensive care units
Laverdiere, M., Labbé, A.-C., Restieri, C., Rotstein, C., Heyland, D., Madger, S., & Stewart, T. (2007) · Journal of Critical Care · doi:10.1016/j.jcrc.2006.10.038 · Cited by 42 · cited 2×
“Bille and Glauser (1997) tested 30 isolates of C. parapsilosis, Laverdiere et al. (2007) tested 14, and Fleck et al. (2007) tested 19 isolates; all were susceptible to fluconazole and amphothericin B.”
BackgroundKovacicova, G., Krupova, Y., Lovaszova, M., Obertik, T., Krcmery, V., Roidova, A., Trupl, J., Liskova, A., Hanzen, J., Milosovic, P., et al. (2000) · Journal of Infection and Chemotherapy · doi:10.1007/s101560070006 · Cited by 39 · cited 1×
“Similarly, Sarvikivi et al. (2005) observed fluconazole resistance in only one C. parapsilosis isolate during a 10-year period of fluconazole prophylaxis and Kovacicova et al. (2000) reported resistance in only two strains of C. parapsilosis, over a period of 3 years.”
BackgroundResistance of Candida parapsilosis to drugs
Camougrand, N., Velours, G., & Guerin, M. (1986) · Biology of the Cell · doi:10.1111/j.1768-322x.1986.tb00489.x · Cited by 20 · cited 2×
“1993), and resistance to drugs and inhibitors (Camougrand et al. 1986).”
Background
Cited by
Donnelly, J. P., Chen, S. C., Kauffman, C. A., Steinbach, W. J., Baddley, J. W., Verweij, P. E., Clancy, C. J., Wingard, J. R., Lockhart, S. R., Groll, A. H., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciz1008 · Cited by 2,917
Self-citationGenomic perspectives on the evolution of fungal entomopathogenicity in Beauveria bassiana
Xiao, G., Ying, S.-H., Zheng, P., Wang, Z.-L., Zhang, S., Xie, X.-Q., Shang, Y., St. Leger, R. J., Zhao, G.-P., Wang, C., et al. (2012) · Scientific Reports · doi:10.1038/srep00483 · Cited by 693
Berkow, E. L., Manigaba, K., Parker, J. E., Barker, K. S., Kelly, S. L., & Rogers, P. D. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01358-15 · Cited by 95
Zhang, L., Xiao, M., Watts, M. R., Wang, H., Fan, X., Kong, F., & Xu, Y.-C. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1086-6 · Cited by 62
Comparative Evolution of Morphological Regulatory Functions in Candida Species
Lackey, E., Vipulanandan, G., Childers, D. S., & Kadosh, D. (2013) · Eukaryotic Cell · doi:10.1128/ec.00164-13 · Cited by 61
Metadata
- Authors
- van Asbeck, E. C., Clemons, K. V., & Stevens, D. A.
- Venue
- Critical Reviews in Microbiology
- Publisher
- Informa UK Limited
- Published
- 2009-10-12
- Volume
- 35
- Issue
- 4
- Pages
- 283-309
- ISSN
- 1040-841X (ISSN-L)
- 1549-7828
- OpenAlex
- W2115869334
- Cited by
- 210
- References
- 36
- FWCI
- 8.38
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.